Muscle Protein Miro1 May Offer a New Clue to Insulin Resistance in Type 2 Diabetes

Insulin resistance occurs when the body's cells respond less effectively to insulin, making it harder to move glucose from the bloodstream into tissues. Skeletal muscle is a major site of glucose use, so impaired insulin response in muscle can contribute to high blood sugar and the development or progression of type 2 diabetes.

The reported study investigated Miro1, a protein found at elevated levels in skeletal muscle from people with type 2 diabetes. Researchers reported that removing Miro1 restored insulin responsiveness in experimental models. They also found that exercise reduced Miro1 levels in participants with obesity and type 2 diabetes and was associated with improvements in insulin sensitivity.

These findings help explain a possible biological mechanism behind insulin resistance and provide a potential target for future treatment development. However, the results do not establish that a Miro1-targeting medicine is available or that manipulating this protein will cure diabetes in humans.

Exercise remains an important part of diabetes management, alongside appropriate medication, nutrition and clinical monitoring. Patients should not change their prescribed treatment based on early laboratory findings.